skip to Main Content

AIM-HI Women’s Venture Competition
Thursday, September 24, 2020

The AIM-HI Accelerator Fund thanks our generous sponsors and dedicated supporters for a fabulous evening on September 24, 2020, celebrating our 8 amazing semi-finalists and their companies at the Awards Ceremony for the inaugural Women’s Venture Competition. The Awards Ceremony started with revealing the People’s Choice Award for Best Pitch winner, Dr. María José Alonso of Libera Bio, and moved to announcing our top two Finalists, selected by the judging committee, Dr. Stacy Blain of Concarlo Holdings and Dr. Manijeh Goldberg of Privo Technologies.

The top finalist of the Women’s Venture Competition will receive an equity investment of $300,000 from the AIM-HI Accelerator Fund. These funds will serve as seed money for proof of concept and proof of value on the path to clinical trials, and eventually, to new effective therapeutics and diagnostics that will eventually save patients’ lives.

Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!

Congratulations to Our Top Finalists!

Stacy Blain, Ph.D.

Stacy Blain, Ph.D.

Founder & CSO, Concarlo Holdings

Manijeh Goldberg, Ph.D.

Manijeh Goldberg, Ph.D.

CEO, Privo Technologies

People’s Choice Award for Best Pitch

Winner

Our sincere thanks to each and everyone who participated in the People’s Choice Award for “Best Pitch”! 

By asking the public to select a favorite out of the 8 semi-finalists based on their one-minute pitch videos, the AIM-HI Women’s Venture Competition wishes to increase the visibility of these early stage oncology start-ups, spread the word about their innovative technologies and help highlight  their marketing skills.

María José Alonso, Ph.D.

María José Alonso, Ph.D.

Founder & CSO, Libera Bio

Keynote Speaker

Deepa Narayanan, MS, CCDM

Deepa Narayanan, MS, CCDM

Program Director & Team Leader, SBIR/STTR Programs at National Cancer Institute

We welcome Deepa Narayanan as our Awards Ceremony Keynote Speaker for this exciting event.

Deepa is an experienced professional with expertise in commercialization of innovative healthcare technologies and a  successful background in translation of oncology products to the clinic. Her experience includes non-dilutive funding strategies, portfolio management of oncology startups, identifying technology gaps, technology development, multi-center clinical trials, regulatory approval and market launch, as well as collaborating with key opinion leaders. With a special focus on connecting innovators with high-value funding and non-funding resources, Deepa has over 15 years of experience in academic, commercial and government sectors.

Judging Committee Chairs

Barbara Weber, M.D., Chair

Barbara Weber, M.D., Chair

President & CEO, Tango Therapeutics

Raju Kucherlapati, Ph.D., Co-Chair

Raju Kucherlapati, Ph.D., Co-Chair

Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Selection Committee Chairs

Pamela Garzone, Ph.D., Chair

Pamela Garzone, Ph.D., Chair

Chief Medical Officer, Calibr at Scripps Research

Webster Cavenee, Ph.D., Co-chair

Webster Cavenee, Ph.D., Co-chair

Director of Strategic Alliances, Ludwig Institute for Cancer Research

Partner Organizations

NFCR-logo

Sponsor Organizations

Microsoft
Scripps Research
Dorsey
Incutabe
GoMo Health
BLA Regulatory
NEA
SamsaraBioCapital
Back To Top